Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Exponent (EXPO) over the last 16 years, with Q4 2025 value amounting to $620.6 million.

  • Exponent's Treasury Shares rose 1377.2% to $620.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $620.6 million, marking a year-over-year increase of 1377.2%. This contributed to the annual value of $545.0 million for FY2025, which is 158.67% up from last year.
  • Per Exponent's latest filing, its Treasury Shares stood at $15.8 million for Q4 2025, which was up 545.44% from $15.2 million recorded in Q3 2025.
  • In the past 5 years, Exponent's Treasury Shares ranged from a high of $15.8 million in Q4 2025 and a low of -$553000.0 during Q2 2022
  • For the 5-year period, Exponent's Treasury Shares averaged around $9.1 million, with its median value being $14.2 million (2021).
  • In the last 5 years, Exponent's Treasury Shares skyrocketed by 4833.59% in 2022 and then soared by 118.23% in 2025.
  • Quarter analysis of 5 years shows Exponent's Treasury Shares stood at $340.8 million in 2021, then skyrocketed by 48.34% to $505.5 million in 2022, then increased by 6.13% to $536.5 million in 2023, then grew by 1.67% to $545.5 million in 2024, then rose by 13.77% to $620.6 million in 2025.
  • Its Treasury Shares stands at $620.6 million for Q4 2025, versus $580.1 million for Q3 2025 and $552.6 million for Q2 2025.